Cargando…

Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly

The feasibility of the noninvasive assessment of blood ‘coagulability’ (the tendency to coagulate) has been tested by using a novel device, the Thrombo-Monitor. It monitors, by using the principles of near infra-red (NIR) dynamic light scattering, the tendency of blood to create clots. The Thrombo-M...

Descripción completa

Detalles Bibliográficos
Autores principales: Lerman, Yaffa, Werber, Moshe M, Fine, Ilya, Kemelman, Polina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262344/
https://www.ncbi.nlm.nih.gov/pubmed/22287870
http://dx.doi.org/10.2147/JBM.S13544
_version_ 1782221709132169216
author Lerman, Yaffa
Werber, Moshe M
Fine, Ilya
Kemelman, Polina
author_facet Lerman, Yaffa
Werber, Moshe M
Fine, Ilya
Kemelman, Polina
author_sort Lerman, Yaffa
collection PubMed
description The feasibility of the noninvasive assessment of blood ‘coagulability’ (the tendency to coagulate) has been tested by using a novel device, the Thrombo-Monitor. It monitors, by using the principles of near infra-red (NIR) dynamic light scattering, the tendency of blood to create clots. The Thrombo-Monitor observes the very initial changes of blood viscosity, which occurs due to the temporarily induced stasis of capillary blood of the finger. One hundred and fifteen patients aged >65 years (matched by age and sex) participated in the study. Patients were initially divided into four groups based on the patient’s medical therapy. The study groups were: warfarin, enoxaparin, aspirin and/or clopidogrel, and a control group. The medications were given according to the patient’s comorbidities (eg, atrial fibrillation [AF], status post pulmonary embolism [S/p PE], status post cerebrovascular accident [S/p CVA]). The Thrombo-Monitor Index (TMI) is a noninvasive index, derived on the basis of laboratory test results of international normalized ratio (INR) and prothrombin time (PT) values. For the group of patients who were treated only with warfarin, TMI was adjusted by using the jackknife statistical approach to create maximum correlation and linearity with INR and PT values that ranged from 1.1 to 5.0. For all warfarin patients (N = 35) the TMI was found to have a good correlation with INR and PT values (R(2) = 0.64, P < 0.00001); mean TMI = 1.86 (SD = 0.91); mean INR and PT = 2.3 (SD = 0.91). The calibration curve thus generated was used to calculate the TMI for all other groups: aspirin group, mean TMI = 1.3 (SD = 0.14, N = 23), corresponding approximately to INR and PT values of 1.036; enoxaparin group (N = 24), mean TMI = 1.34 (SD = 0.304), corresponding to mean INR and PT values of 1.07 (SD = 0.3); control group, INR and PT ≥ 1 (N = 32), mean TMI = 1.24 (SD = 0.32). R(2) of all control and warfarin patients (N = 67) was 0.55 (P < 0.00001). In summary, the newly introduced TMI index is significantly correlated with INR and PT values.
format Online
Article
Text
id pubmed-3262344
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-32623442012-01-27 Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly Lerman, Yaffa Werber, Moshe M Fine, Ilya Kemelman, Polina J Blood Med Original Research The feasibility of the noninvasive assessment of blood ‘coagulability’ (the tendency to coagulate) has been tested by using a novel device, the Thrombo-Monitor. It monitors, by using the principles of near infra-red (NIR) dynamic light scattering, the tendency of blood to create clots. The Thrombo-Monitor observes the very initial changes of blood viscosity, which occurs due to the temporarily induced stasis of capillary blood of the finger. One hundred and fifteen patients aged >65 years (matched by age and sex) participated in the study. Patients were initially divided into four groups based on the patient’s medical therapy. The study groups were: warfarin, enoxaparin, aspirin and/or clopidogrel, and a control group. The medications were given according to the patient’s comorbidities (eg, atrial fibrillation [AF], status post pulmonary embolism [S/p PE], status post cerebrovascular accident [S/p CVA]). The Thrombo-Monitor Index (TMI) is a noninvasive index, derived on the basis of laboratory test results of international normalized ratio (INR) and prothrombin time (PT) values. For the group of patients who were treated only with warfarin, TMI was adjusted by using the jackknife statistical approach to create maximum correlation and linearity with INR and PT values that ranged from 1.1 to 5.0. For all warfarin patients (N = 35) the TMI was found to have a good correlation with INR and PT values (R(2) = 0.64, P < 0.00001); mean TMI = 1.86 (SD = 0.91); mean INR and PT = 2.3 (SD = 0.91). The calibration curve thus generated was used to calculate the TMI for all other groups: aspirin group, mean TMI = 1.3 (SD = 0.14, N = 23), corresponding approximately to INR and PT values of 1.036; enoxaparin group (N = 24), mean TMI = 1.34 (SD = 0.304), corresponding to mean INR and PT values of 1.07 (SD = 0.3); control group, INR and PT ≥ 1 (N = 32), mean TMI = 1.24 (SD = 0.32). R(2) of all control and warfarin patients (N = 67) was 0.55 (P < 0.00001). In summary, the newly introduced TMI index is significantly correlated with INR and PT values. Dove Medical Press 2011-08-18 /pmc/articles/PMC3262344/ /pubmed/22287870 http://dx.doi.org/10.2147/JBM.S13544 Text en © 2011 Lerman et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Lerman, Yaffa
Werber, Moshe M
Fine, Ilya
Kemelman, Polina
Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly
title Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly
title_full Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly
title_fullStr Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly
title_full_unstemmed Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly
title_short Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly
title_sort preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262344/
https://www.ncbi.nlm.nih.gov/pubmed/22287870
http://dx.doi.org/10.2147/JBM.S13544
work_keys_str_mv AT lermanyaffa preliminaryclinicalevaluationofanoninvasivedeviceforthemeasurementofcoagulabilityintheelderly
AT werbermoshem preliminaryclinicalevaluationofanoninvasivedeviceforthemeasurementofcoagulabilityintheelderly
AT fineilya preliminaryclinicalevaluationofanoninvasivedeviceforthemeasurementofcoagulabilityintheelderly
AT kemelmanpolina preliminaryclinicalevaluationofanoninvasivedeviceforthemeasurementofcoagulabilityintheelderly